Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
10
04
2019
revised:
13
05
2019
accepted:
21
05
2019
entrez:
3
10
2019
pubmed:
3
10
2019
medline:
3
10
2019
Statut:
epublish
Résumé
Limited data are available regarding clinical implications of lower renal function after living kidney donation. We examined a novel integrated database to study associations between postdonation estimated glomerular filtration rate (eGFR) and use of antihypertensive medication (AHM) treatment after living kidney donation. Study data were assembled by linking national U.S. transplant registry identifiers, serum creatinine (SCr) values from electronic medical records, and pharmacy fill records for 3222 living donors (1989-2016) without predonation hypertension. Estimated GFR (mL/min per 1.73 m The linked database identified an average of 3 postdonation SCr values per donor (range: 1-38). Lower postdonation eGFR (vs ≥75) bore graded associations with higher odds of AHM use (eGFR 30-44: aOR This novel linkage illustrates the ability to identify postdonation kidney function and associate it with clinically meaningful outcomes; lower eGFR after living kidney donation is a correlate of AHM treatment requirements. Further work should define relationships of postdonation renal function, hypertension, and other morbidity measures.
Sections du résumé
BACKGROUND
BACKGROUND
Limited data are available regarding clinical implications of lower renal function after living kidney donation. We examined a novel integrated database to study associations between postdonation estimated glomerular filtration rate (eGFR) and use of antihypertensive medication (AHM) treatment after living kidney donation.
METHODS
METHODS
Study data were assembled by linking national U.S. transplant registry identifiers, serum creatinine (SCr) values from electronic medical records, and pharmacy fill records for 3222 living donors (1989-2016) without predonation hypertension. Estimated GFR (mL/min per 1.73 m
RESULTS
RESULTS
The linked database identified an average of 3 postdonation SCr values per donor (range: 1-38). Lower postdonation eGFR (vs ≥75) bore graded associations with higher odds of AHM use (eGFR 30-44: aOR
CONCLUSIONS
CONCLUSIONS
This novel linkage illustrates the ability to identify postdonation kidney function and associate it with clinically meaningful outcomes; lower eGFR after living kidney donation is a correlate of AHM treatment requirements. Further work should define relationships of postdonation renal function, hypertension, and other morbidity measures.
Identifiants
pubmed: 31576370
doi: 10.1097/TXD.0000000000000913
pmc: PMC6708633
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e474Informations de copyright
Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Am J Transplant. 2016 Dec;16(12):3540-3547
pubmed: 27287605
Clin Transplant. 2018 Aug;32(8):e13302
pubmed: 29851159
Kidney Int. 2014 Jul;86(1):162-7
pubmed: 24284516
Transplantation. 2008 Aug 15;86(3):399-406
pubmed: 18698242
Transpl Int. 2018 Jan;31(1):20-31
pubmed: 28771882
Hypertension. 2016 Feb;67(2):368-77
pubmed: 26754643
JAMA. 1966 Apr 25;196(4):322-4
pubmed: 5952198
Transplantation. 2019 Jun;103(6):1216-1223
pubmed: 30247449
Int J Epidemiol. 2014 Feb;43(1):264-9
pubmed: 24366487
Curr Transplant Rep. 2017;4(4):320-326
pubmed: 29201600
Ann Intern Med. 2006 Aug 1;145(3):185-96
pubmed: 16880460
JAMA. 2014 Feb 12;311(6):579-86
pubmed: 24519297
Am J Transplant. 2018 Dec;18(12):2987-2999
pubmed: 29498196
Am J Transplant. 2019 Jul;19(7):1989-1998
pubmed: 30629312
Clin Transplant. 2014 Mar;28(3):361-7
pubmed: 24547690
Nephrol Dial Transplant. 2008 Dec;23(12):3895-900
pubmed: 18632588
Transplantation. 2010 Sep 15;90(5):575-80
pubmed: 20562736
J Hum Hypertens. 2001 Feb;15(2):99-106
pubmed: 11317188
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Am J Transplant. 2009 Apr;9(4):657-60
pubmed: 19344458
Am J Nephrol. 2014;40(2):174-83
pubmed: 25196154
J Am Soc Nephrol. 2010 Jun;21(6):898-910
pubmed: 20150537
N Engl J Med. 2010 Aug 19;363(8):724-32
pubmed: 20818874
Biostatistics. 2009 Jan;10(1):1-2
pubmed: 18550565
Am J Kidney Dis. 2015 Jul;66(1):114-24
pubmed: 25795073
Clin J Am Soc Nephrol. 2013 Aug;8(8):1406-13
pubmed: 23813555
Am J Transplant. 2018 Oct;18(10):2534-2543
pubmed: 29498216
Am J Kidney Dis. 2013 Sep;62(3):577-86
pubmed: 23523239
N Engl J Med. 2003 Jan 9;348(2):101-8
pubmed: 12519920
Mayo Clin Proc. 2014 Aug;89(8):1126-9
pubmed: 24867395
J Am Soc Nephrol. 2017 Jan;28(1):313-320
pubmed: 27401688
Kidney Int Suppl. 2005 Aug;(97):S68-77
pubmed: 16014104